Article
[Future therapeutics in celiac disease].
Harefuah - 1 Jun 2012
Lerner Aaron
Abstract excerpt
Celiac disease is a common autoimmune disease affecting 1% of the Western populations. It is an inappropriate immune response, in genetically susceptible patients to dietary wheat, rye, barley and oats. Treatment involves a Lifelong gluten-free diet that predisposes to low compliance due to limited variety, high cost and low palatability, imposing social pressure and affecting quality of life. The result is an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
